Intrathecal infusion of a Ca2+-permeable AMPA channel blocker slows loss of both motor neurons and of the astrocyte glutamate transporter, GLT-1 in a mutant SOD1 rat model of ALS
- 31 October 2007
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 207 (2) , 177-185
- https://doi.org/10.1016/j.expneurol.2007.07.011
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Amyotrophic Lateral Sclerosis 2-Deficiency Leads to Neuronal Degeneration in Amyotrophic Lateral Sclerosis through Altered AMPA Receptor TraffickingJournal of Neuroscience, 2006
- Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1G93A miceExperimental Neurology, 2006
- Onset and Progression in Inherited ALS Determined by Motor Neurons and MicrogliaScience, 2006
- Calcium-permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse modelHuman Molecular Genetics, 2004
- Excitotoxic and oxidative cross-talk between motor neurons and glia in ALS pathogenesisTrends in Neurosciences, 2004
- Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in miceHuman Molecular Genetics, 2003
- Endogenous calcium buffering in motoneurones of the nucleus hypoglossus from mouseThe Journal of Physiology, 1998
- Neuroprotective Strategies in a Model of Chronic Glutamate‐Mediated Motor Neuron ToxicityJournal of Neurochemistry, 1995
- Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosisAnnals of Neurology, 1995
- In vitro kainate injury to large, SMI-32(+) spinal neurons is Ca2+ dependentNeuroReport, 1995